Home
XLO
XLO News

Latest Xilio Therapeutics Inc. (XLO) News on December 24, 2024

Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI

GlobeNewswire

5 days ago

Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI

Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer

GlobeNewswire

8 days ago

Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer

After Golden Cross, Xilio Therapeutics, Inc. (XLO)'s Technical Outlook is Bright

Zacks

15 days ago

After Golden Cross, Xilio Therapeutics, Inc. (XLO)'s Technical Outlook is Bright

Here's Why We're Not Too Worried About Xilio Therapeutics' (NASDAQ:XLO) Cash Burn Situation

Simply Wall St.

18 days ago

Here's Why We're Not Too Worried About Xilio Therapeutics' (NASDAQ:XLO) Cash Burn Situation

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

21 days ago

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics Announces Initial Clinical Trial Data from Phase 1C Dose Escalation for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Advanced Solid Tumors

GlobeNewswire

2 months ago

Xilio Therapeutics Announces Initial Clinical Trial Data from Phase 1C Dose Escalation for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Advanced Solid Tumors

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2024 Financial Results

GlobeNewswire

2 months ago

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2024 Financial Results

Xilio Therapeutics to Present Initial Phase 1C Dose Escalation Data for XTX101 (Vilastobart) in Combination with Atezolizumab in a Late-Breaker Poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

GlobeNewswire

2 months ago

Xilio Therapeutics to Present Initial Phase 1C Dose Escalation Data for XTX101 (Vilastobart) in Combination with Atezolizumab in a Late-Breaker Poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Xilio Therapeutics Announces Upcoming Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

GlobeNewswire

3 months ago

Xilio Therapeutics Announces Upcoming Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

GlobeNewswire

4 months ago

Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results

GlobeNewswire

5 months ago

Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results

Can Xilio Therapeutics (NASDAQ:XLO) Afford To Invest In Growth?

Simply Wall St.

6 months ago

Can Xilio Therapeutics (NASDAQ:XLO) Afford To Invest In Growth?

Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors

GlobeNewswire

6 months ago

Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors

Start Proud Opens the Market

CNW Group

7 months ago

Start Proud Opens the Market

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

Associated Press Finance

7 months ago

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

Business Wire

7 months ago

Form 8.3 - Darktrace plc

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

Investor's Business Daily

7 months ago

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

May jobs reports signals Fed's soft landing: US Labor Secretary

Yahoo Finance Video

7 months ago

May jobs reports signals Fed's soft landing: US Labor Secretary

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

Business Wire

7 months ago

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

Notification of major holding in Kindred Group plc

PR Newswire

7 months ago

Notification of major holding in Kindred Group plc

Business Wire

7 months ago

Form 8.3 - DS Smith plc

Gilead and Cartography enter deal to develop cancer therapies

Pharmaceutical Technology

7 months ago

Gilead and Cartography enter deal to develop cancer therapies

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results

GlobeNewswire

7 months ago

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results

Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why

Zacks

8 months ago

Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

9 months ago

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results

Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing

GlobeNewswire

9 months ago

Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program

Business Wire

9 months ago

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program

Gilead bets on Xilio cancer drug as biotech restructures

BioPharma Dive

9 months ago

Gilead bets on Xilio cancer drug as biotech restructures

Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference

GlobeNewswire

10 months ago

Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference

Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference

GlobeNewswire

a year ago

Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference

SPAR Group (NASDAQ:SGRP) Is Very Good At Capital Allocation

Simply Wall St.

a year ago

SPAR Group (NASDAQ:SGRP) Is Very Good At Capital Allocation

Can Flexsteel (FLXS) Run Higher on Rising Earnings Estimates?

Zacks

a year ago

Can Flexsteel (FLXS) Run Higher on Rising Earnings Estimates?

Smart Sand (NASDAQ:SND) Could Be Struggling To Allocate Capital

Simply Wall St.

a year ago

Smart Sand (NASDAQ:SND) Could Be Struggling To Allocate Capital

Horizon Aircraft Enters into Letter of Intent to Purchase $250M of Cavorite X7 Aircraft, with an Option for up to $500M

GlobeNewswire

a year ago

Horizon Aircraft Enters into Letter of Intent to Purchase $250M of Cavorite X7 Aircraft, with an Option for up to $500M

Beam Global CEO Desmond Wheatley Recognized as Business Intelligence Group’s Global Sustainability Hero of the Year

GlobeNewswire

a year ago

Beam Global CEO Desmond Wheatley Recognized as Business Intelligence Group’s Global Sustainability Hero of the Year

Kingstone CEO Letter to Shareholders

ACCESSWIRE

a year ago

Kingstone CEO Letter to Shareholders

Xilio Therapeutics Highlights Recent Advances Across Clinical Pipeline and Encouraging Preliminary Phase 1 Safety Data for XTX301, a Tumor-Activated IL-12, Further Validating the Promise of Its Tumor-Activated Immuno-Oncology Therapies

GlobeNewswire

a year ago

Xilio Therapeutics Highlights Recent Advances Across Clinical Pipeline and Encouraging Preliminary Phase 1 Safety Data for XTX301, a Tumor-Activated IL-12, Further Validating the Promise of Its Tumor-Activated Immuno-Oncology Therapies

FG Financial Group, Inc. and FG Group Holdings Inc. Sign Definitive Plan of Merger to form Fundamental Global Inc.

GlobeNewswire

a year ago

FG Financial Group, Inc. and FG Group Holdings Inc. Sign Definitive Plan of Merger to form Fundamental Global Inc.

Kopin to Ring Nasdaq Closing Bell on January 16th

Business Wire

a year ago

Kopin to Ring Nasdaq Closing Bell on January 16th

MicroAlgo Inc. Developed QSDLT to Provide a More Secure Foundation for Bitcoin and Other Cryptocurrency Systems

PR Newswire

a year ago

MicroAlgo Inc. Developed QSDLT to Provide a More Secure Foundation for Bitcoin and Other Cryptocurrency Systems

ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®

Business Wire

a year ago

ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®

Burning Rock Announces Results of 2023 Annual General Meeting

GlobeNewswire

a year ago

Burning Rock Announces Results of 2023 Annual General Meeting

We Like These Underlying Return On Capital Trends At L.S. Starrett (NYSE:SCX)

Simply Wall St.

a year ago

We Like These Underlying Return On Capital Trends At L.S. Starrett (NYSE:SCX)

GreenPower Delivers Four Nano BEAST All-Electric, School Buses to West Virginia School Districts

PR Newswire

a year ago

GreenPower Delivers Four Nano BEAST All-Electric, School Buses to West Virginia School Districts

There’s an EV Delivery Event Today. It’s Different From the Cybertruck One.

Barrons.com

a year ago

There’s an EV Delivery Event Today. It’s Different From the Cybertruck One.

IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement

GlobeNewswire

a year ago

IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement

Xilio Therapeutics Announces Initiation of Enrollment for Phase 1 Combination Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, and Updated Phase 1 Monotherapy Data

GlobeNewswire

a year ago

Xilio Therapeutics Announces Initiation of Enrollment for Phase 1 Combination Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, and Updated Phase 1 Monotherapy Data

DLH Reports Fiscal 2023 Fourth Quarter Results

GlobeNewswire

a year ago

DLH Reports Fiscal 2023 Fourth Quarter Results

Odyssey Marine Exploration Secures Strategic Debt Financing Deal

Business Wire

a year ago

Odyssey Marine Exploration Secures Strategic Debt Financing Deal

Business Wire

a year ago

Vince Holding Corp. Announces Participation in the Sidoti Small Cap Conference

Business Wire

a year ago

Vince Holding Corp. Announces New Chief Financial Officer

Ralph Lauren veteran takes CFO job at Vince

Retail Dive

a year ago

Ralph Lauren veteran takes CFO job at Vince

Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023

GlobeNewswire

a year ago

Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023

First Trust Mortgage Income Fund Increases its Monthly Common Share Distribution to $0.0825 Per Share for December

Business Wire

a year ago

First Trust Mortgage Income Fund Increases its Monthly Common Share Distribution to $0.0825 Per Share for December

Identiv Sets Fourth Quarter 2023 Investor Conference Schedule

Business Wire

a year ago

Identiv Sets Fourth Quarter 2023 Investor Conference Schedule

The L.S. Starrett Company Announces Fiscal 2024 First Quarter Results

Business Wire

a year ago

The L.S. Starrett Company Announces Fiscal 2024 First Quarter Results

aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023

GlobeNewswire

a year ago

aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023

FG Group Holdings Inc. (NYSE:FGH) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

FG Group Holdings Inc. (NYSE:FGH) Q3 2023 Earnings Call Transcript

AudioEye, Inc. (NASDAQ:AEYE) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

AudioEye, Inc. (NASDAQ:AEYE) Q3 2023 Earnings Call Transcript

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q3 2023 Earnings Call Transcript

Wood Pellet Exporter Enviva's Stock Is Tumbling Again

The Wall Street Journal

a year ago

Wood Pellet Exporter Enviva's Stock Is Tumbling Again

Down -26.73% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround

Zacks

a year ago

Down -26.73% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround

Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023

GlobeNewswire

a year ago

Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results

GuruFocus.com

a year ago

The Oncology Institute Inc (TOI) Reports Q3 2023 Results: Revenue Up, Net Loss Widens

Verano Holdings Corp. (VRNOF) Reports Q3 Loss, Lags Revenue Estimates

Zacks

a year ago

Verano Holdings Corp. (VRNOF) Reports Q3 Loss, Lags Revenue Estimates

STILWELL JOSEPH Acquires Shares in Sound Financial Bancorp Inc

GuruFocus.com

a year ago

STILWELL JOSEPH Acquires Shares in Sound Financial Bancorp Inc

ProQR Announces Third Quarter 2023 Operating and Financial Results

GlobeNewswire

a year ago

ProQR Announces Third Quarter 2023 Operating and Financial Results

U.S. GOLDMINING TARGETS EXPANSION AT THE WHISTLER GOLD-COPPER PROJECT, ALASKA

CNW Group

a year ago

U.S. GOLDMINING TARGETS EXPANSION AT THE WHISTLER GOLD-COPPER PROJECT, ALASKA

Thomson Reuters StreetEvents

a year ago

Q3 2023 AudioEye Inc Earnings Call

AudioEye Inc (AEYE) Reports Record Third Quarter 2023 Results with Non-GAAP Profit of $300,000

GuruFocus.com

a year ago

AudioEye Inc (AEYE) Reports Record Third Quarter 2023 Results with Non-GAAP Profit of $300,000

Share on Social Networks: